更正：关键时机：手术延迟对Ⅰ-Ⅱ期非小细胞肺癌预后的影响
Correction: Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.
出版信息
PLoS One. 2025 Jul 22;20(7):e0328912. doi: 10.1371/journal.pone.0328912. eCollection 2025.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0319357.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0319357。]
相似文献
1
Correction: Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.
PLoS One. 2025 Jul 22;20(7):e0328912. doi: 10.1371/journal.pone.0328912. eCollection 2025.
2
Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.
PLoS One. 2025 May 28;20(5):e0319357. doi: 10.1371/journal.pone.0319357. eCollection 2025.
3
Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.
BMJ. 2010 Jan 21;340:b5569. doi: 10.1136/bmj.b5569.
4
The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer.
BMC Cancer. 2025 Jul 21;25(1):1197. doi: 10.1186/s12885-025-14445-w.
5
Identifying Diagnostic MicroRNAs and Investigating Their Biological Implications in Rectal Cancer.
JAMA Netw Open. 2021 Dec 1;4(12):e2136913. doi: 10.1001/jamanetworkopen.2021.36913.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
8
Management of Patients With Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline.
Chest. 2025 Sep;168(3):810-827. doi: 10.1016/j.chest.2025.06.023. Epub 2025 Jun 23.
9
Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2022 Nov;164(5):1318-1326.e3. doi: 10.1016/j.jtcvs.2022.02.046. Epub 2022 Mar 10.
10
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Cochrane Database Syst Rev. 2001(2):CD002935. doi: 10.1002/14651858.CD002935.
本文引用的文献
1
Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.
PLoS One. 2025 May 28;20(5):e0319357. doi: 10.1371/journal.pone.0319357. eCollection 2025.
Zotero 插件